IP Library Granted Patent US 10,006,004
Granted Patent B2
US 10,006,004 · App. 12/416,715 · Granted Jun 26, 2018

Multipotent adult stem cells and methods for isolation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,006,004
App. No.
12/416,715
Granted
Jun 26, 2018
Kind
B2
Abstract

The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells.

Claims (12)

1. A cell culture comprising isolated expanded human multipotent non-embryonic, non-germ cells that can differentiate into at least one cell type of at least two of the endodermal, ectodermal, and mesodermal embryonic lineages, said cells having undergone at least 10-40 cell doublings in culture.

2. The cell culture of claim 1 wherein the non-embryonic, non-germ cells express one or more of oct4, telomerase, rex-1, rox-1, or sox-2.

3. The cell culture of claim 1 wherein the non-embryonic, non-germ cells can differentiate into at least one cell type of each of the endodermal, ectodermal, and mesodermal embryonic lineages.

4. The cell culture of claim 3 wherein the non-embryonic, non-germ cells express one or more of oct4, telomerase, rex-1, rox-1, or sox-2.

5. A method for making a cell culture composition, said method comprising introducing the isolated expanded human non-embryonic, non-germ cells of claim 1 into cell culture medium.

6. A method for making the cell culture of claim 1 , the method comprising:

a. obtaining the non-embryonic, non-germ cells from non-embryonic, non-germ tissue containing the cells, and

b. culturing the non-embryonic, non-germ cells to produce a cell culture in which the non-embryonic, non-germ cells have undergone 10-40 cell doublings.

7. A method for producing a differentiated progeny cell, said method comprising culturing the cells from the cell culture of claim 1 under conditions that are suitable to induce differentiation, thereby producing a differentiated progeny cell.

8. The cell culture as in any of claims 1 - 4 , in which the isolated expanded human multipotent non-embryonic, non-germ cells are derived from bone marrow.

9. The method of claim 5 wherein the isolated expanded human multipotent non-embryonic, non-germ cells are derived from bone marrow.

10. The method of claim 6 wherein the isolated expanded human multipotent non-embryonic, non-germ cells are derived from bone marrow.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2024
From: ABT HOLDING COMPANY; ATHERSYS, INC.; ADVANCED BIOTHERAPEUTICS, INC.; REGENESYS BVBA; REGENESYS, LLC
To: HEALIOS K.K.
Reel/Frame 067606/0139 →
RELEASE OF SECURITY INTEREST Recorded May 29, 2024
From: HEALIOS K.K.
To: ABT HOLDING COMPANY; ATHERSYS, INC.; ADVANCED BIOTHERAPEUTICS, INC.; REGENESYS BVBA; REGENESYS, LLC
Reel/Frame 067566/0638 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 1, 2024
From: ABT HOLDING COMPANY; ATHERSYS, INC.; ADVANCED BIOTHERAPEUTICS, INC.; REGENESYS BVBA; REGENESYS, LLC
To: HEALIOS K.K.
Reel/Frame 066435/0775 →